https://www.selleckchem.com/products/fg-4592.html
In recent years, an increasing spectrum of systemic therapies has become available in the field of dermatology. Some of these drugs are used off-label, which for example can lead to problems with reimbursement. This article is therefore intended to provide an overview of the currently approved systemic therapies in dermatology and to point out further alternatives such as Compassionate Use and Early Access Programs. The search for approved drugs in Germany was conducted online in the database for drugs of the Federal Institute for Drugs